| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 09/03/1998 | WO1998038174A1 Pyrazine compounds |
| 09/03/1998 | WO1998038173A1 Atropisomers of 3-aryl-4(3h)-quinazolinones and their use as ampa-receptor antagonists |
| 09/03/1998 | WO1998038170A1 Substituted benzimidazoles and their use for treating retroviral infection |
| 09/03/1998 | WO1998038167A1 Heteroaryl-hexanoic acid amide derivatives, their preparation and their use as selective inhibitors of mip-1-alpha binding to its ccr1 receptor |
| 09/03/1998 | WO1998038165A1 S-2'-(2-(1-methyl-2-piperidyl) ethyl) cinnamanilide as a 5-ht2 receptor antagonist |
| 09/03/1998 | WO1998038164A1 Selective epoxidation process for preparing pharmaceutical compounds |
| 09/03/1998 | WO1998038163A1 N-hydroxy-2-(alkyl, aryl, or heteroaryl sulfanyl, sulfinyl or sulfonyl)-3-substituted alkyl, aryl or heteroarylamides as matrix metalloproteinase inhibitors |
| 09/03/1998 | WO1998038158A1 Process for preparing pharmaceutical compounds |
| 09/03/1998 | WO1998038155A1 5-hydroxymethyl-2-aminotetralins as cardiovascular agents |
| 09/03/1998 | WO1998038154A1 Hydroxymethyl derivatives of 2-amino-1,2,3,4-tetrahydronaphthalene as cardiovascular agent |
| 09/03/1998 | WO1998037919A1 USE OF NUCLEIC ACIDS CONTAINING UNMETHYLATED CpG DINUCLEOTIDE IN THE TREATMENT OF LPS-ASSOCIATED DISORDERS |
| 09/03/1998 | WO1998037918A1 Staphylococcus 3-dehydroquinate synthase |
| 09/03/1998 | WO1998037917A1 Novel processes implementing selective immune down regulation (sidr) |
| 09/03/1998 | WO1998037912A1 A new composite vaccine which contains antigen, antibody and recombinant dna and its preparing method |
| 09/03/1998 | WO1998037901A1 Self-regulated apoptosis of inflammatory cells by gene therapy |
| 09/03/1998 | WO1998037900A1 Use of the rna chosen instead of a protein in production of bioactive substances or for specific immunity control |
| 09/03/1998 | WO1998037899A1 Liver protection or treatment agents comprising asiatic acid derivatives as the active component |
| 09/03/1998 | WO1998037898A1 Synergistically acting anti-fungal agents that are inhibitors of folate metabolism, especially methotrexate and sulfamethoxazole |
| 09/03/1998 | WO1998037897A1 Method for reducing coronary artery reactivity |
| 09/03/1998 | WO1998037896A1 Treatment of eosinophil-associated pathologies, such as bronchial asthma, with synergistic combinations of glucocorticoids and a local anesthetics |
| 09/03/1998 | WO1998037895A1 Drugs for ameliorating pulmonary circulation |
| 09/03/1998 | WO1998037894A1 Synergistic combination of pde inhibitors and adenylate cyclase agonists or guanyl cyclyse agonists |
| 09/03/1998 | WO1998037892A1 Tamoxifen as a therapy to reduce irinotecan hydrochloride-induced diarrhea |
| 09/03/1998 | WO1998037891A1 Antimicrobial agent for agriculture |
| 09/03/1998 | WO1998037890A1 Antimicrobial agent |
| 09/03/1998 | WO1998037889A1 Use of descarboethoxyloratadine for the manufacture of a medicament for the treatment of urinary incontinence, motion sickness and vertigo |
| 09/03/1998 | WO1998037888A1 Thrombolytic agent |
| 09/03/1998 | WO1998037887A1 Anticancer composition comprising a diaminotrifluoromethylpyridine derivative |
| 09/03/1998 | WO1998037886A1 Topical nifedipine preparations for the conservative treatment of functional pathologies of the anal canal |
| 09/03/1998 | WO1998037885A1 N-oxides of heterocyclic esters, amides, thioesters, and ketones |
| 09/03/1998 | WO1998037884A1 Inclusion complexes in aqueous solution |
| 09/03/1998 | WO1998037883A1 Forskohlin for promoting lean body mass |
| 09/03/1998 | WO1998037882A1 Method of using neurotrophic carbamates and ureas |
| 09/03/1998 | WO1998037881A1 Method of treating or preventing septic shock by administering a mek inhibitor |
| 09/03/1998 | WO1998037880A1 Inhibitors of leaderless protein export |
| 09/03/1998 | WO1998037879A1 Nimesulide gel systems for topical use |
| 09/03/1998 | WO1998037877A1 N-hydroxy-2-(alkyl, aryl or heteroaryl sulfanyl, sulfinyl or sulfonyl)-3-substituted alkyl, aryl or heteroarylamides as matrix metalloproteinase inhibitors |
| 09/03/1998 | WO1998037876A1 Pharmaceutical composition for the programmed release of dexfenfluramine |
| 09/03/1998 | WO1998037875A1 Drug composition |
| 09/03/1998 | WO1998037874A1 Oral preparation for the prophylactic and therapeutic treatment of helicobacter sp. infection |
| 09/03/1998 | WO1998037873A2 Method for reducing secretion of apolipoprotein b in animals by administering conjugated linoleic acid |
| 09/03/1998 | WO1998037872A2 Transdermal drug delivery system for the administration of tamsulosin, and related compositions and methods of use |
| 09/03/1998 | WO1998037871A1 Transdermal device for the delivery of testosterone |
| 09/03/1998 | WO1998037870A1 Transdermal delivery of basic drugs using nonpolar adhesive systems and acidic solubilizing agents |
| 09/03/1998 | WO1998037868A2 Nimesulide topical formulations in the form of liquid crystals |
| 09/03/1998 | WO1998037867A1 Mixtures of alkylphosphoric acid esters and their use as cosmetic and pharmaceutical emulsifiers |
| 09/03/1998 | WO1998037859A1 An oral composition suitable for use in oral hygiene and dental care |
| 09/03/1998 | WO1998037765A1 7-methylthiooxomethyl and 7-methylthiodioxomethyl paclitaxels |
| 09/03/1998 | WO1998037764A1 Nucleic acid sequences for atp-binding cassette transporter |
| 09/03/1998 | WO1998028317A3 Synthesis of nucleosides and polynucleotides |
| 09/03/1998 | WO1998026770A3 The topical use of kappa opioid agonists to treat ocular pain |
| 09/03/1998 | WO1998026767A3 Site-specific controlled release dosage formulation for mesalamine |
| 09/03/1998 | WO1998025573A3 The use of celastrol to treat alzheimer's disease |
| 09/03/1998 | WO1998024764A3 Substituted benzamide derivatives and pharmaceutical compositions containing them |
| 09/03/1998 | WO1998024397A3 Administration of products of the 5-lipoxygenase metabolic pathway to enhance antimicrobial defense |
| 09/03/1998 | WO1998016205A3 Stable glassy state powder formulations |
| 09/03/1998 | WO1998008855A3 N6 heterocyclic substituted adenosine derivatives |
| 09/03/1998 | DE19707800A1 Mischungen von Alkylphosphorsäureestern und deren Verwendung als kosmetische und pharmazeutische Emulgatoren Mixtures of alkylphosphoric esters and their use as cosmetic and pharmaceutical emulsifiers |
| 09/03/1998 | CA2282836A1 Compositions for treating or preventing prostatic cancer |
| 09/03/1998 | CA2282729A1 Transgenic animals and cell lines for screening drugs effective for the treatment or prevention of alzheimer's disease |
| 09/03/1998 | CA2282707A1 Factor x analogues with a modified protease cleavage site |
| 09/03/1998 | CA2282656A1 N-hydroxy-2-(alkyl, aryl, or heteroaryl sulfanyl, sulfinyl or sulfonyl)-3-substituted alkyl, aryl or heteroarylamides as matrix metalloproteinase inhibitors |
| 09/03/1998 | CA2282655A1 N-hydroxy-2-(alkyl, aryl or heteroaryl sulfanyl, sulfinyl or sulfonyl)-3-substituted alkyl, aryl or heteroarylamides as matrix metalloproteinase inhibitors |
| 09/03/1998 | CA2282639A1 Treatment of eosinophil-associated pathologies, such as bronchial asthma, with synergistic combinations of glucocorticoids and a local anesthetics |
| 09/03/1998 | CA2282552A1 Substituted benzimidazoles and their use for treating retroviral infection |
| 09/03/1998 | CA2282455A1 Hydroxymethyl derivatives of 2-amino-1,2,3,4-tetrahydronaphthalene as cardiovascular agent |
| 09/03/1998 | CA2282396A1 Use of descarboethoxyloratadine for the manufacture of a medicament for the treatment of urinary incontinence, motion sickness and vertigo |
| 09/03/1998 | CA2282388A1 5-hydroxymethyl-2-aminotetralins as cardiovascular agents |
| 09/03/1998 | CA2282264A1 7-methylthiooxomethyl and 7-methylthiodioxomethyl paclitaxels |
| 09/03/1998 | CA2281925A1 Inhibitors of leaderless protein export |
| 09/03/1998 | CA2281887A1 Nucleic acid sequences for atp-binding cassette transporter |
| 09/03/1998 | CA2281876A1 Transdermal device for the delivery of testosterone |
| 09/03/1998 | CA2281838A1 Use of nucleic acids containing unmethylated cpg dinucleotide in the treatment of lps-associated disorders |
| 09/03/1998 | CA2281664A1 Reverse hydroxamate derivatives as metalloprotease inhibitors |
| 09/03/1998 | CA2281582A1 Antimicrobial agent |
| 09/03/1998 | CA2281567A1 Self-regulated apoptosis of inflammatory cells by gene therapy |
| 09/03/1998 | CA2281108A1 Process for preparing pharmaceutical compounds |
| 09/03/1998 | CA2281107A1 Tripeptide and tetrapeptide pharmaceutical compounds |
| 09/03/1998 | CA2281104A1 Selective epoxidation process for preparing pharmaceutical compounds |
| 09/03/1998 | CA2281096A1 Method of using neurotrophic carbamates and ureas |
| 09/03/1998 | CA2280980A1 Pharmaceutical composition for the programmed release of dexfenfluramine |
| 09/03/1998 | CA2280855A1 Tamoxifen as a therapy to reduce irinotecan hydrochloride-induced diarrhea |
| 09/03/1998 | CA2280744A1 Anticancer composition |
| 09/03/1998 | CA2279887A1 Method for reducing secretion of apolipoprotein b in animals by administering conjugated linoleic acid |
| 09/03/1998 | CA2279277A1 Nimesulide gel systems for topical use |
| 09/03/1998 | CA2278674A1 Heterocyclic compounds and their use for inhibiting .beta.-amyloid peptide |
| 09/03/1998 | CA2253717A1 Drugs for ameliorating pulmonary circulation |
| 09/03/1998 | CA2252790A1 Novel processes implementing selective immune down regulation (sidr) |
| 09/03/1998 | CA2198988A1 P28 bap31 a bcl-2 associated protein and use thereof for the modulation of apoptosis |
| 09/02/1998 | EP0861903A1 Method for reversible immobilizing oligo and/or polysaccharides |
| 09/02/1998 | EP0861898A1 Rat Cathepsin K polynucleotide & polypeptide sequence |
| 09/02/1998 | EP0861896A2 Cell volume regulated human kinase h-sgk |
| 09/02/1998 | EP0861839A1 Selective epoxidation process for preparing cryptophycin compounds and intermediates |
| 09/02/1998 | EP0861838A2 Process and intermediates for preparing cryptophycin compounds |
| 09/02/1998 | EP0861837A1 2-Aminoindane derivatives, process for their preparation and pharmaceutical compositions containing them |
| 09/02/1998 | EP0861836A1 Sulfonamido substituted condensed, seven-membered ring compounds with potassium channel blocking activity |
| 09/02/1998 | EP0861830A1 Use of 1,4-naphthoquinone and 1,4-dihydroxynaphthalene pyrrole derivatives for dyeing keratinous material, compounds and compositions containing them |
| 09/02/1998 | EP0861666A2 Pharmaceutical composition for use in treatment of diabetes |
| 09/02/1998 | EP0861662A1 Nasal spray for treating viral common colds |
| 09/02/1998 | EP0861661A2 Method of providing an osmotic agent for a peritoneal dialysis solution |